Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03222973
Brief Title: Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS) (AFFINITY)

First Submitted : July 17, 2017
First Submitted that Met QC Criteria : July 17, 2017
First Posted : July 19, 2017

Last Update Submitted that Met QC Criteria : March 24, 2021
Last Update Posted : March 25, 2021